{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1360298341124100736.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1002/anie.199416321"}},{"identifier":{"@type":"URI","@value":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fanie.199416321"}},{"identifier":{"@type":"URI","@value":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/anie.199416321"}}],"dc:title":[{"@value":"An Unusual Route to Potential Platinum Antitumor Compounds: Synthesis, Reactivity, and Spectroscopic Properties of the Pt<sup>IV</sup>Complex<i>fac</i>‐[PtCl<sub>3</sub>(NH<sub>3</sub>)<sub>2</sub>L]Cl"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380298341124100736","@type":"Researcher","foaf:name":[{"@value":"Ulrich Bierbach"}]},{"@id":"https://cir.nii.ac.jp/crid/1380298341124100737","@type":"Researcher","foaf:name":[{"@value":"Jan Reedijk"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"05700833"}],"prism:publicationName":[{"@value":"Angewandte Chemie International Edition in English"}],"dc:publisher":[{"@value":"Wiley"}],"prism:publicationDate":"1994-09-02","prism:volume":"33","prism:number":"15-16","prism:startingPage":"1632","prism:endingPage":"1634"},"reviewed":"false","dc:rights":["http://onlinelibrary.wiley.com/termsAndConditions#vor"],"url":[{"@id":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fanie.199416321"},{"@id":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/anie.199416321"}],"createdAt":"2003-12-31","modifiedAt":"2024-12-14","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/2050870367085358720","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Dual-action Pt(Ⅳ) prodrugs and targeted delivery in metal-organic frameworks : overcoming cisplatin resistance and improving anticancer activity"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1002/anie.199416321"},{"@type":"CROSSREF","@value":"10.1246/bcsj.20220218_references_DOI_Gmbgl2hbvNdcJML3mrn7Vowue2l"}]}